Novosanis will be present at the EACR Conference on Liquid Biopsies in Bergamo, Italy between May 24-26 2022. Our team is excited to participate in latest scientific discussions on the role...
We're excited to attend the 29th European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Amsterdam, Netherlands, from 13 - 16 April 2019. Hope to see...
Vanessa Vankerckhoven, CEO and Koen Beyers, CTO will be attending JP Morgan in San Francisco, US from Jan 7 to 10, 2019. Do schedule a meeting and talk to us!
Novosanis is looking forward to join a new edition of EUROGIN from December 2 to 5 in Lisbon, Portugal. A large number of abstracts with fresh new data have been submitted. Looking forward...
Novosanis is looking forward to joining MEDICA, the leading international trade fair for the medical sector taking place in the Messe in Düsseldorf, Germany from 12 - 15 November 2018.
Novosanis is excited to join ESMO for the first time and showcase our Colli-Pee device for first-void urine sampling and our VAX-ID drug delivery platform. Come and talk to our CEO, Vanessa...
Novosanis is attending the IPVC 2018 conference in Sydney, Australia from October 2 to October 6, 2018. Excited to present our latest results on the Colli-Pee device suited for (home-based...
Being ISO13485 is all about continuous improvement and learning. Novosanis is attending RAPS Convergence in Vancouver, Canada to gain more insights in regulatory approvals all over the...
Novosanis will be present at the Brazilian Clinical Pathology Conference from September 25 to 28, 2018 in Brazil where we will launch our Colli-Pee device for the Brazilian market. Do come...
Novosanis will be attending AACC in Chicago, US from July 30 to Agust 2, 2018. Our Sales & Business Development Director LATAM & US, Jeane Brunmark is excited to meet you and...
Novosanis
